Preventing drug-drug interactions with HIV ART
A shortage of mental health-care providers, coupled with pharmacists’ unique skills and access to patients, has led to a significant opportunity for community and health-system pharmacists to aid in detection of depression and in medication selection and counseling for patients with depression.
Pharmacists can become the perfect partner in the battle against Alzheimer’s disease. Details here.
The goal of this activity is to prepare pharmacists with the knowledge they need to provide contemporary pharmacologic therapy to patients with hyperlipidemia.
The goal of this activity is to assist pharmacists in managing difficult-to-treat symptoms of Parkinson’s disease.
Arizona has become the latest state to limit opioid prescriptions—a trend that has some healthcare providers and experts concerned.
When pharmacists get involved in patient care, significant improvements are often seen. Diabetes management is one of the most notable examples.
While many aspects of diabetes care are universal, patients with type I diabetes (T1D) often face a unique set of obstacles and challenges.
Despite evidence that optimal glycemic control can help reduce disease progression and complications, most patients do not achieve recommended treatment goals.
Daclizumab is the first subcutaneous injectable monoclonal antibody to be approved for the treatment of MS.